HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endocrine and metabolic response to muscarinic stimulation and inhibition in the ruminant: effects of slaframine.

Abstract
The influence of slaframine (SF), a parasympathomimetic compound isolated from the fungus Rizoctonia leguminicola, on circulating metabolic hormone concentrations was investigated in goats. In Exp. 1, SF was administered i.v. at 0 (CONT), 50 (LSF), 100 (MSF), or 150 (HSF) microgram/kg.75 BW in four mature Spanish-cross does (average BW 36 +/- 7 kg) fitted with indwelling jugular vein catheters in a 4 x 4 Latin square design. Plasma glucose peaked (P < .06) at 120 min with LSF and at 180 min with HSF and was higher (P <.06) than the CONT at these times. Glucose exhibited a quadratic response (P < .03) to SF. Area under the response curve for glucose differed (P < .02) in HSF from CONT and MSF. Insulin peaked (P < .01) at 240 min with MSF and at 180 min with HSF. Plasma triiodothyronine was maintained at a higher level (P < .03) with HSF. Thyroxine peaked (P < .06) at 120 min with MSF and 300 min with HSF. Plasma NEFA and somatotropin concentrations were not affected (P > .10) by SF. In Exp. 2, four mature Spanish-cross wethers (average BW 27 +/- 2 kg) fitted with jugular vein catheters were administered SF (0 and 114 micrograms/kg.75 BW) and 4-diphenylacetoxy-N-methylpiperidine methiodide (4DAMP; 0 and 258 micrograms/kg.75 BW), a M3-muscarinic receptor antagonist, i.v. in a 4 x 4 Latin square design with a 2 x 2 factorial arrangement of treatments. With SF, glucose peaked (P < .06) at 60 min and insulin peaked (P < .05) at 180 min. Plasma triiodothyronine levels were maintained (P < .05) with SF but declined with other treatments. Plasma NEFA and thyroxine concentrations remained unchanged regardless of treatment. Slaframine administration induced hyperglycemia and hyperinsulinemia in goats; however, these changes were blocked by preadministration of isomolar quantities of the M3-muscarinic receptor antagonist, 4DAMP.
AuthorsA M Chapa, J M Fernandez, D L Thompson Jr, R J Tempelman, L F Berrio, W J Croom Jr, W M Hagler Jr
JournalJournal of animal science (J Anim Sci) Vol. 73 Issue 12 Pg. 3673-80 (Dec 1995) ISSN: 0021-8812 [Print] United States
PMID8655443 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulin
  • Muscarinic Agonists
  • Muscarinic Antagonists
  • Parasympathomimetics
  • Piperidines
  • Receptors, Muscarinic
  • Triiodothyronine
  • slaframine
  • 4-diphenylacetoxy-1,1-dimethylpiperidinium
  • Growth Hormone
  • Thyroxine
Topics
  • Alkaloids (administration & dosage, pharmacology)
  • Animals
  • Blood Glucose (analysis)
  • Endocrine Glands (drug effects, physiology)
  • Fatty Acids, Nonesterified (blood)
  • Female
  • Goat Diseases (blood, chemically induced)
  • Goats (blood, physiology)
  • Growth Hormone (blood)
  • Hyperglycemia (blood, chemically induced, veterinary)
  • Hyperinsulinism (blood, chemically induced, veterinary)
  • Injections, Intravenous (veterinary)
  • Insulin (blood)
  • Male
  • Muscarinic Agonists (administration & dosage, pharmacology)
  • Muscarinic Antagonists (administration & dosage, pharmacology)
  • Parasympathomimetics (administration & dosage, pharmacology)
  • Piperidines (administration & dosage, pharmacology)
  • Receptors, Muscarinic (drug effects, physiology)
  • Thyroxine (blood)
  • Triiodothyronine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: